57 - Re-envisioning Your Infectious Diseases Curricula through a Non-oppressive/Anti-racist Lens

Thursday, September 30, 2021

5:15 PM - 6:30 PM EDT

Moderator(s)

Christopher Ohl, MD

Professor of Medicine
Infectious Diseases
Wake Forest Baptist Health System
Winston Salem, NC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

AW

Alexandre White, PhD

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Erica Johnson, MD

Assistant Professor of Medicine, Division of Infectious Diseases
Johns Hopkins
Baltimore, MD, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Yvonne Maldonado, MD

Professor
Pediatrics - Infectious Diseases
Stanford University
Stanford, CA, United States

Pfizer (Individual(s) Involved: Self): ccontracted research, Stanford Principal Investigator Pfizer maternal RSV trial and Pfizer pediatric COVID vaccine trials., Consultant, contracted research, Stanford Principal Investigator Pfizer maternal RSV trial and Pfizer pediatric COVID vaccine trials., Data Safety Monitoring Board, Pfizer non-COVID Vaccine trial, Grant/Research Support, Grant/Research Support

Participants should be aware of the following financial/non-financial relationships:

Christopher Ohl, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Alexandre R. White, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Erica N. Johnson, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Yvonne A. Maldonado, MD: Pfizer (Individual(s) Involved: Self): ccontracted research, Stanford Principal Investigator Pfizer maternal RSV trial and Pfizer pediatric COVID vaccine trials., Consultant, contracted research, Stanford Principal Investigator Pfizer maternal RSV trial and Pfizer pediatric COVID vaccine trials., Data Safety Monitoring Board, Pfizer non-COVID Vaccine trial, Grant/Research Support, Grant/Research Support

Learning Objectives:

At the conclusion of this session, participants will be able to:

develop an understanding of the historical breadth of structural racism in medicine and infectious diseases
discuss the current influence of structural racism on the training of infectious diseases medical practitioners and their practice of medicine
incorporate concepts and ideas into ID curricula to mitigate oppression and structural racism

Presentations:

Historical context of structural racism within medicine and ID
Speaker: Alexandre R. White, PhD
Incorporating these ideas into ID curricula
Speaker: Erica N. Johnson, MD – Johns Hopkins
Structural racism in health care and ID in 2021 and its effects on the practice of medicine
Speaker: Yvonne A. Maldonado, MD – Stanford University